TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30833491

Group type: EXPERIMENTAL
Intervention: Intravenous methylprednisolone (250 mg at anesthetic induction and 250 mg at initiation of cardiopulmonary bypass)
Number of subjects: 7286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7286
Study: 28685884

Group type: EXPERIMENTAL
Intervention: Recent Injection Drug Use (IDU)
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Contextual factors related to IDU
Number of subjects: 400
Study: 25187158

Group type: EXPERIMENTAL
Intervention: Biological treatment (specifics not provided)
Number of subjects: 35
Study: 23981692

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid 1 g 10‐min bolus followed by 1 g eight‐hour infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 19239602

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 103

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 103
Study: 15063813

Group type: EXPERIMENTAL
Intervention: Pamidronate (30 mg per treatment) given at 3-month intervals for 12 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 11590925

Group type: EXPERIMENTAL
Intervention: Triple-drug regimen with abacavir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PI-containing triple-drug combinations
Number of subjects: 0

Group type: COMPARATOR
Intervention: PI-sparing regimens
Number of subjects: 0
Study: 9591958

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (50 mg/day)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Beta-carotene (20 mg/day)
Number of subjects: 941

Group type: EXPERIMENTAL
Intervention: Combined alpha-tocopherol and beta-carotene
Number of subjects: 941

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 941
Study: 8149030

Group type: EXPERIMENTAL
Intervention: Single 1.5 gram dose of cefuroxime plus three doses of placebo
Number of subjects: 295

Group type: COMPARATOR
Intervention: Four 1 gram doses of cefazolin
Number of subjects: 295
Study: 3409623

Group type: EXPERIMENTAL
Intervention: Impedance plethysmography (QZp)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Venous occlusion strain gauge plethysmography (Qsg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Venous occlusion plethysmography (QZocc)
Number of subjects: 6
Study: 12206948

Group type: EXPERIMENTAL
Intervention: Low back pain patients under slow breathing (0.1 Hz)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Low back pain patients under fast breathing (0.5 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects under slow breathing (0.1 Hz)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy subjects under fast breathing (0.5 Hz)
Number of subjects: 20
Study: 31083232

Group type: EXPERIMENTAL
Intervention: Brain education-based meditation (BEM)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Health education classes
Number of subjects: 48
Study: 30207526

Group type: EXPERIMENTAL
Intervention: Isotretinoin, folic acid, and vitamin B12
Number of subjects: 66

Group type: COMPARATOR
Intervention: Isotretinoin alone
Number of subjects: 66
Study: 27909125

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 111
Study: 25117066

Group type: EXPERIMENTAL
Intervention: PK-guided 5-FU dosing
Number of subjects: 70
Study: 22985896

Group type: EXPERIMENTAL
Intervention: 5.25% sodium hypochlorite (NaOCl)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 2% chlorhexidine gel (CLX)
Number of subjects: 126
Study: 20139674

Group type: EXPERIMENTAL
Intervention: Accelerated infant growth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal infant growth
Number of subjects: 0
Study: 18996244

Group type: EXPERIMENTAL
Intervention: AM-PAC Physical Mobility scale
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: AM-PAC Personal Care scale
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: SF-36 PF
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: SPPB
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: PFP-10
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Gait speed
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: 6MWT
Number of subjects: 108
Study: 15830986

Group type: EXPERIMENTAL
Intervention: Microdiscectomy
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Intradiscal ozone injection
Number of subjects: 300

Group type: COMPARATOR
Intervention: Microdiscectomy and Intradiscal ozone injection
Number of subjects: 300
Study: 12439835

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study: 10348358

Group type: EXPERIMENTAL
Intervention: Alpha-adrenergic blocking agent (phentolamine mesylate, 20 ml infused at 2 ml/min)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo (physiological saline, 20 ml infused at 2 ml/min)
Number of subjects: 9
Study: 8630553

Group type: EXPERIMENTAL
Intervention: Practice guideline intervention
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 146
Study: 1940488

Group type: EXPERIMENTAL
Intervention: 50 mg oral morphine in fasted state
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: 50 mg oral morphine in fed state
Number of subjects: 5
Study: 7146305

Group type: EXPERIMENTAL
Intervention: Foster Grandparent intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: No visitors (Control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parent visitors
Number of subjects: 0
Study: 30786906

Group type: EXPERIMENTAL
Intervention: Health educational intervention based on the IMB model
Number of subjects: 372

Group type: COMPARATOR
Intervention: Health education on breastfeeding (Control)
Number of subjects: 372
Study: 29871651

Group type: EXPERIMENTAL
Intervention: MEDIHEALTH program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 26313229

Group type: EXPERIMENTAL
Intervention: 100 mg BR-DIM, twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 200 mg BR-DIM, twice daily
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo, twice daily
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 400 mg BR-DIM, twice daily
Number of subjects: 45
Study: 23826649

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Diode laser
Number of subjects: 21
Study: 22404223

Group type: COMPARATOR
Intervention: Contingency Management (CM) for abstinence alone
Number of subjects: 127

Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy (CBT) alone
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: CM combined with CBT
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: CBT combined with CM
Number of subjects: 127
Study: 19947264

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with TDP
Number of subjects: 112
Study: 17711715

Group type: EXPERIMENTAL
Intervention: MCE-guided TASH
Number of subjects: 72

Group type: COMPARATOR
Intervention: AP-guided TASH
Number of subjects: 72
Study: 15144473

Group type: EXPERIMENTAL
Intervention: Myrmecia pilosula ant venom immunotherapy (VIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Various in vitro tests (IgE RAST, leucocyte SI, IL-4 production, LRT, BAT)
Number of subjects: 0
Study: 12167382

Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 9646001

Group type: EXPERIMENTAL
Intervention: Method 1: Cotton-tipped swab and cervical brush for HPV testing
Number of subjects: 115

Group type: COMPARATOR
Intervention: Method 2: Cyto standard cylindrical cytology brush and Dacron-tipped swab for HPV testing
Number of subjects: 115
Study: 7641465

Group type: EXPERIMENTAL
Intervention: Total knee prosthetic designs with low to moderate conformity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Total knee prosthetic designs with moderate to high conformity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All designs tested
Number of subjects: 0
Study: 2473995

Group type: EXPERIMENTAL
Intervention: Direct inoculation of the Vitek AutoMicrobic system
Number of subjects: 226

Group type: COMPARATOR
Intervention: Routine methods
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Direct method
Number of subjects: 226
Study: 779855

Group type: EXPERIMENTAL
Intervention: L-tryptophan
Number of subjects: 16
Study: 31631859

Group type: EXPERIMENTAL
Intervention: Laparoscopic supracervical hysterectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Endometrial ablation
Number of subjects: 0
Study: 28292282

Group type: EXPERIMENTAL
Intervention: Aerobic interval training plus healthy lifestyle counselling (16 supervised training lessons, 6 group and 3 individual meetings)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Low-to-moderate intensity continuous training plus healthy lifestyle counselling (16 supervised training lessons, 6 group and 3 individual meetings)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Healthy lifestyle counselling without any supervised physical exercise (6 group and 3 individual meetings)
Number of subjects: 105
Study: 26054104

Group type: EXPERIMENTAL
Intervention: Electric vacuum aspiration in UHR
Number of subjects: 392

Group type: COMPARATOR
Intervention: Method chosen according to patients' features in UHS
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Antibiotic prophylaxis in UHR
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Cervical priming with Laminaria in UHS
Number of subjects: 392
Study: 23463651

Group type: EXPERIMENTAL
Intervention: Aerobic training (AT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Combination training (ATRT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Nonexercise control
Number of subjects: 52
Study: 21321152

Group type: EXPERIMENTAL
Intervention: Low-gradient severe aortic stenosis
Number of subjects: 1525

Group type: COMPARATOR
Intervention: Moderate aortic stenosis
Number of subjects: 1525

Group type: EXPERIMENTAL
Intervention: Low-gradient severe aortic stenosis with reduced stroke volume index (≤ 35 mL/m²)
Number of subjects: 1525

Group type: COMPARATOR
Intervention: Patients with normal stroke volume index
Number of subjects: 1525
Study: 19064281

Group type: EXPERIMENTAL
Intervention: Budesonide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nedocromil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16864815

Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTXA) 50 units/0.25 mL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Isotonic saline (0.25 mL)
Number of subjects: 30
Study: 12615873

Group type: EXPERIMENTAL
Intervention: Levofloxacin
Number of subjects: 938

Group type: COMPARATOR
Intervention: Beta-lactam therapy (including cefuroxime and amoxicillin)
Number of subjects: 938

Group type: COMPARATOR
Intervention: Cefuroxime
Number of subjects: 938

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 938

Group type: COMPARATOR
Intervention: Beta-lactam therapy
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: CDAD positive patients
Number of subjects: 938
Study: 10844622

Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs) 3.6 g three times daily with meals for three months
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Essential amino acids (EAAs)
Number of subjects: 52
Study: 9228227

Group type: EXPERIMENTAL
Intervention: Conventional therapy with additional ultrasound treatment for 12 weeks (30 kHz continuous ultrasound 100 mW/cm2 three times a week)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional therapy with topical application of hydrocolloid dressings and compression therapy
Number of subjects: 24
Study: 8440857

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Combined endurance and strength training
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Stationary cycle
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Walking
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Aerobic movement
Number of subjects: 180
Study: 3446491

Group type: EXPERIMENTAL
Intervention: Edrophonium 0.5 mg kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.05 mg kg‐1
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Edrophonium 1.0 mg kg‐1
Number of subjects: 40
Study: 29334721

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg intravenously every 4 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 28376839

Group type: EXPERIMENTAL
Intervention: Facilitation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Implementation as Usual (IU)
Number of subjects: 0
Study: 27061821

Group type: EXPERIMENTAL
Intervention: Mammographic screening every 18 months
Number of subjects: 11812

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 11812
Study: 23546863

Group type: EXPERIMENTAL
Intervention: Invaginating excision of hernia sac without ligation (Group I)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Excision of the sac at the neck without ligation (Group E)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Transfixion and excision of the sac in the traditional manner (Group L)
Number of subjects: 152
Study: 22937901

Group type: EXPERIMENTAL
Intervention: Alginate impression material
Number of subjects: 85

Group type: COMPARATOR
Intervention: Silicone impression material
Number of subjects: 85

Group type: COMPARATOR
Intervention: Health economic evaluation
Number of subjects: 85
Study: 19437299

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 37
Study: 17264541

Group type: COMPARATOR
Intervention: Nup88 expression in normal mucosa
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Nup88 expression in primary adenocarcinomas
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Nup88 expression in lymph node metastases
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Nup88 expression in ulcerated tumours
Number of subjects: 315

Group type: EXPERIMENTAL
Intervention: Nup88 expression in tumours with different differentiation levels
Number of subjects: 315
Study: 12445840

Group type: EXPERIMENTAL
Intervention: Low-dose prednisone (initial dose: 20 mg/day, maintenance dose: 10 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Meta-analysis including data from three other AD trials
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 0
Study: 10863343

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 8717923

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 0
Study: 1279928

Group type: EXPERIMENTAL
Intervention: Infusions of dextran-40 with pentoxifylline
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: Saline infusions with pentoxifylline
Number of subjects: 382

Group type: COMPARATOR
Intervention: Saline infusions with placebo medication
Number of subjects: 382
Study: 6428171

Group type: EXPERIMENTAL
Intervention: Combined therapy with verapamil (360 mg daily) and atenolol (100 mg daily)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Single drug therapy (either verapamil or atenolol)
Number of subjects: 18
Study: 3094443

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil (1.5 g) with probenecid (1 g)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Amoxicillin (3 g) with probenecid (1 g)
Number of subjects: 117
Study: 31983031

Group type: EXPERIMENTAL
Intervention: Roux-en-Y Gastric Bypass (RYGB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard-of-care medical treatment (control)
Number of subjects: 19
Study: 29886787

Group type: EXPERIMENTAL
Intervention: Transcervical Foley catheter balloon with traction
Number of subjects: 200

Group type: COMPARATOR
Intervention: Transcervical Foley catheter balloon without traction
Number of subjects: 200
Study: 28089102

Group type: EXPERIMENTAL
Intervention: Corticosteroid injection
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Polidocanol
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Autologous blood
Number of subjects: 44
Study: 25707509

Group type: EXPERIMENTAL
Intervention: Basophil allergen threshold sensitivity (CD‐sens) to hazelnut
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: IgE antibodies to hazelnut components (Cor a 9 and Cor a 14)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Serum tryptase levels
Number of subjects: 40
Study: 23917675

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy group
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 19415350

Group type: EXPERIMENTAL
Intervention: RelyX Unicem Applicator (RUA)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: G-Cem (GC)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Clearfil SA Cement (CSA)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Air-particle abrasion
Number of subjects: 120
Study: 18209581

Group type: EXPERIMENTAL
Intervention: PPI (rabeprazole, lansoprazole, or omeprazole) plus amoxicillin and metronidazole given b.i.d. for 7 days
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Presence of metronidazole resistance
Number of subjects: 169
Study: 17000910

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg/d
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: High postoperative CRP levels
Number of subjects: 200

Group type: COMPARATOR
Intervention: Atorvastatin 40 mg/d and Placebo
Number of subjects: 200
Study: 14624763

Group type: EXPERIMENTAL
Intervention: Three times weekly GH injections
Number of subjects: 20

Group type: COMPARATOR
Intervention: Daily GH injections
Number of subjects: 20
Study: 11097698

Group type: COMPARATOR
Intervention: Ketamine
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: Ketamine and midazolam
Number of subjects: 266
Study: 9112967

Group type: EXPERIMENTAL
Intervention: Lumbo-sacral selective posterior rhizotomy (SPR) plus intensive physiotherapy
Number of subjects: 30

Group type: COMPARATOR
Intervention: Intensive physiotherapy alone
Number of subjects: 30
Study: 1350364

Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms BID
Number of subjects: 2277

Group type: EXPERIMENTAL
Intervention: Salmeterol 100 micrograms BID
Number of subjects: 2277

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 2277
Study: 3919745

Group type: EXPERIMENTAL
Intervention: lysine acetyl salicylate (LAS)
Number of subjects: 30

Group type: COMPARATOR
Intervention: morphine
Number of subjects: 30
Study: 30379212

Group type: EXPERIMENTAL
Intervention: Osseotite
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Nanotite
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: SLActive
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: SLA
Number of subjects: 19
Study: 27058471

Group type: EXPERIMENTAL
Intervention: 5-week resilience program
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study: 24477299

Group type: EXPERIMENTAL
Intervention: 30 g of ethanol/d as gin or beer
Number of subjects: 74

Group type: COMPARATOR
Intervention: nonalcoholic beer
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: beer
Number of subjects: 74
Study: 22914465

Group type: EXPERIMENTAL
Intervention: Enoxaparin 40 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 40
Study: 20570264

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol gel (0.06%)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Oral tibolone (2.5 mg)
Number of subjects: 69
Study: 18950294

Group type: EXPERIMENTAL
Intervention: Patients with left bundle branch block (LBBB)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Patients with right bundle branch block (RBBB)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Patients without bundle branch block (no BBB)
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: Patients with bundle branch block (BBB)
Number of subjects: 310
Study: 16162191

Group type: EXPERIMENTAL
Intervention: Quality‐of‐Life Therapy (QOLT)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Supportive Therapy (ST)
Number of subjects: 35
Study: 15569557

Group type: EXPERIMENTAL
Intervention: Amoxicillin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cefuroxime
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0
Study: 11076820

Group type: EXPERIMENTAL
Intervention: Folic acid (5 mg) and vitamin B(12) (1 mg) daily (n=59)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (n=30)
Number of subjects: 89
Study: 8805892

Group type: EXPERIMENTAL
Intervention: EMLA 1 ml + GTN 2 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EMLA 2 ml + GTN 2 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: EMLA 2 ml only
Number of subjects: 0
Study: 1634449

Group type: EXPERIMENTAL
Intervention: Ibudilast (20 mg twice daily orally)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Disodium chromoglycate
Number of subjects: 13

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 13
Study: 6236436

Group type: EXPERIMENTAL
Intervention: Nightly ipratropium bromide (160 micrograms)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Nightly salbutamol (200 micrograms)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nightly salbutamol plus ipratropium bromide
Number of subjects: 14
Study: 31060367

Group type: EXPERIMENTAL
Intervention: Pressure release technique for 60 seconds (T60s)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Pressure release technique for 90 seconds (T90s)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Pressure release technique for 30 seconds (T30s)
Number of subjects: 60
Study: 27913796

Group type: EXPERIMENTAL
Intervention: Assisted intention monitoring (AIM)
Number of subjects: 74
Study: 27480182

Group type: COMPARATOR
Intervention: MICT (30 min at 60-70% HRpeak, five times/week)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 4HIIT (4×4 min bouts at 85-95% HRpeak, three times/week)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 1HIIT (1×4 min bout at 85-95% HRpeak, three times/week)
Number of subjects: 66
Study: 25804039

Group type: EXPERIMENTAL
Intervention: ET 90 mg four days or more a week
Number of subjects: 40

Group type: COMPARATOR
Intervention: ET 90 mg 3 days or less a week
Number of subjects: 40